Former biotech execs in ‘brazen fraud’ case want indictments dismissed


Nader Pourhassan, the former CEO of Vancouver-based CytoDyn, also wants his case severed from that of his co-defendant.

Previous Boston Scientific CEO joins CVS board of directors
Next Sendero Health Plans names new CEO